Status:
TERMINATED
Visual Outcomes After Vivity Toric IOL Implantation
Lead Sponsor:
EVP Eye Care
Collaborating Sponsors:
Alcon Research
Icon Eye Care
Conditions:
Refractive Assessment
Eligibility:
All Genders
45+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate patient satisfaction after bilateral implantation of Vivity Toric Extended Vision Intraocular lens and visual outcomes.
Detailed Description
To evaluate and report outcomes including postoperative uncorrected visual acuity, postoperative best corrected visual acuity, postoperative refractive error, and IOL rotational stability after Vivity...
Eligibility Criteria
Inclusion
- Calculated lens power within study IOL range of 15.0 diopters to 25.0 diopters and toric range of T3 to T6
- Willing and able to comprehend informed consent form and to complete 1 day and 3-4 month postoperative visit
- Potential postoperative best corrected distance visual acuity of 20/20 or better in each eye based on medical opinion of investigator
Exclusion
- Ocular pathology or comorbidity that could reduce potential postoperative best corrected distance visual acuity
- Ocular trauma or zonular weakness/instability
- Diagnosis of glaucoma or high-risk glaucoma suspect
- Previous refractive surgery
- Unreliable preoperative biometry measurements
- Severe dry eye or ocular surface disease
Key Trial Info
Start Date :
January 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 13 2021
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT04675489
Start Date
January 15 2021
End Date
December 13 2021
Last Update
January 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icon Eye Care
Grand Junction, Colorado, United States, 81501